Literature DB >> 34228721

MiDAS-Meaningful Immunogenetic Data at Scale.

Maciej Migdal1, Dan Fu Ruan2, William F Forrest3, Amir Horowitz2, Christian Hammer4,5.   

Abstract

Human immunogenetic variation in the form of HLA and KIR types has been shown to be strongly associated with a multitude of immune-related phenotypes. However, association studies involving immunogenetic loci most commonly involve simple analyses of classical HLA allelic diversity, resulting in limitations regarding the interpretability and reproducibility of results. We here present MiDAS, a comprehensive R package for immunogenetic data transformation and statistical analysis. MiDAS recodes input data in the form of HLA alleles and KIR types into biologically meaningful variables, allowing HLA amino acid fine mapping, analyses of HLA evolutionary divergence as well as experimentally validated HLA-KIR interactions. Further, MiDAS enables comprehensive statistical association analysis workflows with phenotypes of diverse measurement scales. MiDAS thus closes the gap between the inference of immunogenetic variation and its efficient utilization to make relevant discoveries related to immune and disease biology. It is freely available under a MIT license.

Entities:  

Year:  2021        PMID: 34228721     DOI: 10.1371/journal.pcbi.1009131

Source DB:  PubMed          Journal:  PLoS Comput Biol        ISSN: 1553-734X            Impact factor:   4.475


  1 in total

1.  Allelic variation in HLA-DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro.

Authors:  Christian Hammer; Jane Ruppel; Lynn Kamen; Julie Hunkapiller; Ira Mellman; Valerie Quarmby
Journal:  Clin Transl Sci       Date:  2022-04-08       Impact factor: 4.438

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.